Lineage Cell Therapeutics, Inc. Financial Ratios — LCTX

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	-81.47	-116.09	-66.16	-98	40.54	-14.08	-36.13	-11.36	-19.34	-43.61	-30.14	-29.97	-25.19	-97.95
Return on Assets (%)	-33.33	-56.7	-100.33	-54.91	-55.43	28.3	-12.65	-33.46	-10.31	-17.69	-30.46	-17.62	-19.13	-17.37	-56.27
Return on Capital (%)	- -	- -	- -	- -	- -	40.79	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-54.59	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	95.24	74.35	72.28	57.01	56.31	84.1	90.62	78.67	72.12	50.19	63.4	95.05	92.5	96.48	99
EBITDA Margin (%)	-979.13	-1,309.45	-1,208.46	-2,171.08	-2,347.08	-2,407.19	-2,084.82	-2,663.98	-2,427.33	-3,157.57	-1,240.71	-148.22	-268.76	-219.7	-144.82
Operating Margin (%)	-1,120.98	-1,476.82	-1,346.63	-2,603.08	-2,597.04	-2,618.43	-2,268.75	-2,895.13	-2,630.31	-3,421.35	-1,263.12	-153.17	-276.5	-226.11	-149.62
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-1,106.43	-1,494.85	-1,964.03	-2,627.38	-2,472.38	826.87	-1,299.61	-3,328.39	-1,301.35	-2,836.22	-1,110.63	-175.56	-260.28	-195.62	-471.61
Profit Margin (%)	-990.74	-1,265.64	-1,533.83	-1,870.16	-1,854.42	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Net Income to Common Margin (%)	-990.74	-1,265.64	-1,533.83	-1,874.63	-1,870.8	1,490.76	-1,114.73	-3,247.88	-792.22	-2,671.28	-1,104.18	-178.69	-240.2	-195.9	-436.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	0.17	0.6	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-81.47	-116.09	-66.05	-97.42	40.54	-14.08	-36.13	-11.36	-19.34	-43.61	-30.14	-29.97	-25.19	-97.95

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
ST Debt	- -	- -	- -	- -	- -	1	- -	- -	1	1	1	1	1	1	1
LT Debt	- -	- -	- -	- -	5	3	1	2	4	3	2	3	2	1	2
Total Debt/EBITDA	- -	- -	- -	-0.01	-0.09	-0.07	-0.04	-0.06	-0.14	-0.16	-0.06	-0.18	-0.12	-0.12	-0.11
Net Debt/EBITDA	1.36	0.2	0.16	0.69	0.7	0.37	0.98	0.62	0.26	1.31	1.15	0.52	1.47	2.19	1.94
Total Debt/EBIT	- -	- -	- -	-0.01	-0.08	-0.07	-0.04	-0.06	-0.13	-0.14	-0.06	-0.17	-0.12	-0.12	-0.11
Net Debt/EBIT	1.19	0.17	0.14	0.58	0.63	0.34	0.9	0.57	0.24	1.21	1.13	0.5	1.43	2.13	1.87
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	75.66	60.26	99.91	70.31	46.57	85.26	93.62	90.9	90.57	92.51	55.82	62.19	65.82	71.77	43.05
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.57	4.98	2.06	0.71	2.1	3.37	2.48	1.99	3.71	3.04	1.65	3.15
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
Net Debt to Equity	-53.58	-17.91	-13	-46.82	-54.4	-15.33	-22.32	-25.49	-8.54	-33.7	-61.32	-15.78	-57.14	-59.46	-94.11
Net Debt/Capital (%)	-87.88	-15.38	-6.9	-54.93	-72.22	-17.24	-28.53	-33.84	-8.83	-45.78	-129.13	-16.69	-108.71	-125.06	-458.64
EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
EBITDA-CapEx	-17	-23	-37	-43	-65	-57	-39	-41	-36	-24	-49	-22	-25	-21	-22
Operating Income (Loss)	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	7.06	0.99	0.79	4.17	3.45	2.57	5.55	4.51	4.73	5.35	1.24	3.05	1.98	3.42	4.91
Current Ratio	7.93	1.64	1.14	4.58	3.79	2.9	6.2	5.34	8.86	5.66	2.37	3.16	2.14	3.65	5.2
Quick Ratio	7.06	0.99	0.95	4.37	3.58	2.7	5.99	5.06	8.42	5.35	2.32	3.06	2.02	3.47	4.99
CFO/Avg Current Liab	-4.83	-5.22	-5.2	-5.54	-4.56	-3.97	-3.88	-4.51	-4.8	-2.77	-0.86	0.03	-1.55	-1.45	-1.49
Common Equity/Total Assets	75.66	60.26	99.91	70.31	46.57	85.26	93.62	90.9	90.57	92.51	55.82	62.19	65.82	71.77	43.05
Long-Term Debt/Equity (%)	- -	- -	- -	0.75	6.5	2.18	0.71	2.12	3.55	2.67	2.17	4.09	3.34	1.77	3.61
Long-Term Debt/Capital (%)	- -	- -	- -	0.57	4.98	2.06	0.71	2.1	3.37	2.48	1.99	3.71	3.04	1.65	3.15
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.63	5.25	2	0.67	1.93	3.14	2.35	1.13	2.38	2.05	1.2	1.39
Total Debt/Equity (%)	- -	- -	- -	0.84	6.68	3.05	0.93	2.46	4.65	4.02	3.08	5.42	4.76	3.26	5.58
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt/Total Assets (%)	- -	- -	- -	0.7	5.39	2.79	0.88	2.23	4.12	3.54	1.61	3.15	2.92	2.22	2.15
CFO/Total Liabilities	-310.97	-360.81	-190.78	-319.05	-244.57	-350.85	-339.91	-328.04	-224.49	-154.06	-28.17	2.05	-73.25	-63.78	-27.32
CFO/CapEx	-14.13	-49.1	-12.96	-55.35	-8.35	-16.76	-23.01	-9.4	-72.61	-308.64	-69.3	2.56	-42.38	-40.87	-36.24
Altman's Z-Score	32.14	-6.77	-20.82	1.4	2.66	14.1	14.09	2.64	-1.28	3.31	-1.83	-5.53	-10.51	-8.72	-5.98

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	5.13	1.81	2.39	2.96	2.92	1.83	2.73	4.82	0.15	0.58	17.17	13.74	19.04
Days Sales Outstanding	- -	- -	71.14	202.2	152.68	123.5	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventory Turnover	1.64	8.16	6.78	3.76	8.29	716	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	222.14	44.75	53.85	96.96	44.02	0.51	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.15	0.38	0.4	0.32	0.33	0.16	0.13	0.18	0.17	0.15	0.46	0.25	0.3	0.21	0.08
Accounts Payable Turnover Days	2,397.8	951.68	916.67	1,131.71	1,104.32	2,244.7	2,749.45	1,992.39	2,120.01	2,388.14	787.59	1,488.08	1,208.42	1,761.62	4,393.75
Cash Conversion Cycle	-2,175.66	-906.93	-791.68	-832.54	-907.62	-2,120.69	-2,624.59	-1,793.01	-1,986.16	-2,312.36	1,594.09	-853.34	-1,187.16	-1,735.05	-4,374.58
Inventory to Cash Days	-222.14	-44.75	17.28	105.24	108.67	122.99	124.86	199.38	133.85	75.79	2,381.68	634.73	21.26	26.57	19.17
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	273	155	195	248	327	351	246	115	130	264	403	199	188	101	384
- Cash & Cash Equivalents	22	4	5	29	42	22	37	24	9	33	56	11	35	46	41
+ Preferred Equity and Hybrid Capital	- -	- -	- -	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	13	15	27	26	51	13	2	-2	-2	-1	-1	-1	-1	-1	-1
+ Total Debt	- -	- -	- -	1	5	4	2	2	5	4	3	4	3	3	2
Enterprise Value	264	165	217	249	340	345	211	85	102	225	346	143	154	54	330
Total Capital	47	33	85	83	100	138	165	93	117	103	99	79	68	82	50
Total Debt/Capital (%)	- -	- -	- -	0.64	5.11	2.88	0.93	2.43	4.41	3.73	2.83	4.91	4.34	3.05	4.87
Total Debt / EV	- -	- -	- -	- -	0.02	0.01	0.01	0.03	0.05	0.02	0.01	0.03	0.02	0.05	0.01
EV/Sales	158.36	97.4	75.91	127.75	134	153.27	117.8	60.32	69.19	291.42	88.85	9.74	17.25	5.68	22.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	135.29	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	97.33	- -	- -	- -
Diluted Market Cap	273	155	195	248	327	359	246	115	130	264	403	199	188	101	384
Diluted Enterprise Value	264	165	217	249	340	354	212	93	123	234	349	190	154	56	345
EV per Share	5.61	3.35	4.01	3.74	4.26	3.55	1.84	0.67	0.7	1.5	2.1	0.84	0.89	0.27	1.43
TTM Sales	2	2	3	2	3	2	2	1	1	1	4	15	9	9	15
TTM EBITDA	-16	-22	-35	-42	-59	-54	-37	-38	-36	-24	-48	-22	-24	-21	-21
TTM Operating Income	-19	-25	-39	-51	-66	-59	-41	-41	-39	-26	-49	-23	-25	-21	-22
TTM Cash Flow to Firm	-14	-20	-30	-39	-45	-42	-31	-31	-32	-20	-24	1	-29	-23	-19
TTM Free Cash Flow to Firm	-13	-19	-27	-38	-39	-40	-29	-28	-32	-20	-23	1	-28	-23	-18

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-21.64	-8.02	-7.17	-6.5	-8.33	-9.03	-8.43	-4.18	-4.11	-13.41	-17.36	134.96	-6.75	-4.47	-20.89
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	264	165	217	249	340	345	211	85	102	225	346	143	154	54	330
Low Price	3.55	2.67	3.15	2.21	2.2	2.02	2.1	0.66	0.53	0.58	1.55	1.02	0.9	0.48	0.37
EV/Sales	158.36	97.4	75.91	127.75	134	153.27	117.8	60.32	69.19	291.42	88.85	9.74	17.25	5.68	22.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	10.46	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-16.35	-9.97	-4.91	-5.81	-6.72	8.72	-16.86	-6.26	-13.2	-7.56	-9.46	-9.05	-10.51	-10.46	-3.74
Price/Earnings High	-27.15	-14.59	-6.2	-7.54	-10	11.62	-21.78	-8.72	-21.5	-14.61	-11.98	-16.64	-12.7	-17.32	-7.57
Price/Earnings Low	-10.11	-6.13	-3.89	-4.02	-3.7	5.86	-12.03	-1.82	-6.64	-4.22	-5.93	-6.59	-7.24	-5.17	-1.32
Price/Book Value	7.88	8.62	3.38	4.71	7.41	2.89	1.52	1.25	1.14	2.64	4.14	2.58	2.83	1.24	7.93
Price/Book Value Average	7.79	11.92	3.73	4.03	7.22	2.41	2.08	3.11	1.36	1.56	4.18	3.09	3.4	2.4	4.9
Price/Book Value High	12.93	17.43	4.72	5.23	10.76	3.21	2.68	4.34	2.22	3.02	5.29	5.68	4.1	3.97	9.92
Price/Book Value Low	4.82	7.33	2.96	2.79	3.98	1.62	1.48	0.91	0.68	0.87	2.62	2.25	2.34	1.19	1.73
Price/Tangible Book Value	11.97	40.59	-49.47	12.17	7.63	2.92	1.56	1.3	2.48	7.06	12.07	13.63	39.3	5.08	394.55
Price/Tangible Book Value Average	11.82	56.11	-54.57	10.41	7.43	2.43	2.14	3.23	2.95	4.17	12.18	16.31	47.15	9.83	243.85
Price/Tangible Book Value High	19.63	82.07	-68.99	13.51	11.07	3.24	2.76	4.5	4.81	8.06	15.42	30	56.97	16.28	493.78
Price/Tangible Book Value Low	7.31	34.51	-43.29	7.21	4.09	1.63	1.53	0.94	1.48	2.33	7.63	11.88	32.47	4.86	86.26
Price/Sales	164	91.28	68.23	127.33	128.97	156	137.35	81.55	87.63	341.63	103.45	13.51	21.04	10.59	26.4
Price/Sales Average	161.98	126.21	75.27	108.93	125.63	130.04	187.89	203.17	104.58	201.89	104.47	16.16	25.24	20.49	16.32
Price/Sales High	269	184.6	95.15	141.33	187.17	173.28	242.75	283.2	170.35	390.15	132.23	29.74	30.5	33.93	33.04
Price/Sales Low	100.21	77.62	59.7	75.45	69.2	87.29	134.15	59.15	52.57	112.6	65.45	11.78	17.38	10.14	5.77
Price/Cash Flow	-20.11	-7.85	-6.62	-6.38	-7.34	-8.3	-8.07	-3.74	-4.05	-13.37	-17.11	187.59	-6.59	-4.36	-20.31
Price/Cash Flow Average	-19.86	-10.86	-7.3	-5.46	-7.15	-6.92	-11.03	-9.32	-4.84	-7.9	-17.27	224.42	-7.9	-8.43	-12.55
Price/Cash Flow High	-32.99	-15.88	-9.22	-7.08	-10.65	-9.22	-14.25	-12.99	-7.88	-15.27	-21.86	412.86	-9.55	-13.96	-25.42
Price/Cash Flow Low	-12.29	-6.68	-5.79	-3.78	-3.94	-4.64	-7.88	-2.71	-2.43	-4.41	-10.82	163.54	-5.44	-4.17	-4.44
Price/Free Cash Flow Average	-21.37	-11.08	-7.91	-5.56	-8.12	-7.53	-11.53	-10.43	-4.91	-7.93	-17.53	161.45	-8.1	-8.64	-12.91
Price/Free Cash Flow High	-35.5	-16.21	-10	-7.21	-12.1	-10.03	-14.9	-14.53	-7.99	-15.32	-22.18	297.02	-9.78	-14.31	-26.14
Price/Free Cash Flow Low	-13.22	-6.82	-6.27	-3.85	-4.47	-5.05	-8.24	-3.04	-2.47	-4.42	-10.98	117.65	-5.58	-4.27	-4.57
EV/Sales Average	156.34	132.33	82.94	109.35	130.96	127.59	169.09	186.99	100.5	163.3	90.54	15.56	21.45	15.79	13.6
EV/Sales High	263.36	190.72	102.82	141.75	192.5	170.83	223.95	267.02	166.26	351.56	118.3	29.13	26.71	29.23	30.32
EV/Sales Low	94.57	83.74	67.38	75.86	74.53	84.84	115.36	42.97	48.48	74.01	51.52	11.18	13.6	5.44	3.05
EV/EBITDA Average	-15.97	-10.11	-6.86	-5.04	-5.58	-5.3	-8.11	-7.02	-4.14	-5.17	-7.3	-10.5	-7.98	-7.19	-9.39
EV/EBITDA High	-26.9	-14.57	-8.51	-6.53	-8.2	-7.1	-10.74	-10.02	-6.85	-11.13	-9.53	-19.66	-9.94	-13.31	-20.94
EV/EBITDA Low	-9.66	-6.4	-5.58	-3.49	-3.18	-3.52	-5.53	-1.61	-2	-2.34	-4.15	-7.54	-5.06	-2.47	-2.11
EV/EBIT Average	-13.95	-8.96	-6.16	-4.2	-5.04	-4.87	-7.45	-6.46	-3.82	-4.77	-7.17	-10.16	-7.76	-6.99	-9.09
EV/EBIT High	-23.49	-12.91	-7.64	-5.45	-7.41	-6.52	-9.87	-9.22	-6.32	-10.28	-9.37	-19.02	-9.66	-12.93	-20.27
EV/EBIT Low	-8.44	-5.67	-5	-2.91	-2.87	-3.24	-5.08	-1.48	-1.84	-2.16	-4.08	-7.3	-4.92	-2.4	-2.04
Last Price	5.81	3.14	3.6	3.73	4.1	3.61	2.15	0.91	0.89	1.76	2.45	1.17	1.09	0.5	1.67
High Price	9.53	6.35	5.02	4.14	5.95	4.01	3.8	3.16	1.73	2.01	3.13	2.58	1.58	1.61	2.09
Enterprise Value Average	261	224	237	213	332	287	303	265	149	126	353	229	192	150	198
Enterprise Value High	439	323	294	276	488	385	401	378	246	272	461	428	239	278	441
Enterprise Value Low	158	142	193	148	189	191	207	61	72	57	201	164	122	52	44

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	49	49	57	78	90	103	127	127	150	153	169	170	175	220	243
Diluted Weighted Avg Shares	47	49	54	66	80	100	114	127	146	150	165	170	173	200	230
Basic Weighted Avg Shares	47	49	54	66	80	97	114	127	146	150	165	170	173	200	230
Revenue per Share	0.04	0.03	0.05	0.03	0.03	0.02	0.02	0.01	0.01	0.01	0.02	0.09	0.05	0.05	0.06
EBITDA per Share	-0.35	-0.45	-0.64	-0.64	-0.75	-0.56	-0.33	-0.3	-0.25	-0.16	-0.29	-0.13	-0.14	-0.1	-0.09
Operating Income per Share	-0.4	-0.51	-0.71	-0.76	-0.83	-0.61	-0.36	-0.32	-0.27	-0.18	-0.3	-0.13	-0.14	-0.11	-0.09
Basic EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Basic EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Diluted EPS, GAAP	-0.35	-0.44	-0.81	-0.55	-0.59	0.34	-0.17	-0.36	-0.08	-0.14	-0.26	-0.15	-0.12	-0.09	-0.28
Diluted EPS from Cont Ops	-0.39	-0.51	-0.98	-0.66	-0.73	0.19	-0.2	-0.37	-0.08	-0.14	-0.26	-0.16	-0.12	-0.09	-0.28
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.29	-0.4	-0.54	-0.58	-0.56	-0.43	-0.27	-0.24	-0.22	-0.13	-0.14	0.01	-0.17	-0.12	-0.08
Free Cash Flow per Basic Share	-0.31	-0.41	-0.59	-0.6	-0.63	-0.46	-0.28	-0.27	-0.22	-0.13	-0.15	- -	-0.17	-0.12	-0.08
Cash & Equivalents per Share	0.47	0.09	0.1	0.44	0.54	0.23	0.33	0.24	0.21	0.28	0.35	0.34	0.21	0.24	0.24
Book Value per Share	0.74	0.36	1.06	0.79	0.55	1.25	1.42	0.73	0.78	0.67	0.59	0.45	0.39	0.41	0.21
Tangible Book Value per Share	0.49	0.08	-0.07	0.31	0.54	1.24	1.37	0.7	0.36	0.25	0.2	0.09	0.03	0.1	- -

Lineage Cell Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)